Related by context. Frequent words. (Click for all words.) 68 Meets Primary Endpoint 67 Receives Orphan Drug Designation 67 Investigational Device Exemption 66 FDA Clearance 66 Fast Track Status 66 Alair System 66 Initiates Phase II 65 Pivotal Phase III 65 Announces FDA Clearance 65 ThermoDox R 65 BioGlue R 65 Phase III Clinical Trial 65 Patient Enrollment 64 Patent Covering 63 MicroThermX 63 Acute Ischemic Stroke 63 FDA Clears 63 PROMUS Element Stent 63 FACTIVE R gemifloxacin 63 Fortical R 63 Inhaled Insulin 63 THALOMID 63 Therapeutic Competitors 62 Develop Novel 62 SBIR Grant 62 Completes Enrollment 62 Diabetic Macular Edema 62 Inc Therapeutic Competitors 62 FDA Accepts 62 ARCOXIA 62 Presents Positive 62 www.vivus.com 62 Initiate Phase 62 MultiCell Technologies 62 Ketotransdel 62 Ixempra 62 Image Guided 62 Surgical Ablation System 62 Milestone Payment 62 Clinical Trial Results 61 Nuclear Pharm Assist 61 Receives FDA Clearance 61 Transcept Pharmaceuticals 61 Pivotal Study 61 optical biosensors 61 Pivotal Trial 61 Surgical Procedures 61 Non Invasive 61 Survival Benefit 61 Aloxi R 61 Enrolls First 61 Improves Survival 61 Pivotal Phase 61 Single Dose 61 Product Differentiation Innovation 61 Drug Shows Promise 60 Recombinant Human 60 REPEL CV 60 VALSTAR 60 Vitro Diagnostic 60 ComfortScan system 60 Phase Ib II 60 Study Evaluating 60 Arthritis Drug 60 Therapeutics TCT scientific 60 #-# Full Text 60 Gastric Cancer 60 Small Molecule 60 Hexvix 60 Cardiovascular Monitoring 60 Trofex 60 Kepivance 60 FORE SIGHT 60 Anti Tumor 60 Commences Phase 60 BEMA TM Fentanyl 60 Patent Issued 60 CORTOSS 60 Application BLA 59 Combidex 59 Azedra 59 k Clearance 59 Pulmonary Arterial Hypertension 59 Tesetaxel 59 submitted Biologics License 59 CryoSeal FS System 59 preclinical efficacy 59 Electronic Brachytherapy 59 Anemia Drug 59 Virtual Colonoscopy 59 Argatroban 59 Full Prescribing Information 59 PSMA ADC 59 Phase III Trial 59 desvenlafaxine 59 Remote Patient Monitoring 59 Anika Therapeutics 59 Pirfenidone 59 supplemental Biologics License Application 59 Overactive Bladder 59 Drug Candidate